Maccura Biotechnology Co.Ltd (SHE:300463)
China · Delayed Price · Currency is CNY 9.06
+0.08 (0.89%)
Nov 2, 2026, 3:04 PM CST
SHE:300463 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 858.47 | 667.19 | 671.45 | 835.96 | 587.35 | 637.16 |
Trading Asset Securities | 35.09 | 50.18 | 60.06 | 311.14 | 663.72 | - |
Cash & Short-Term Investments | 893.56 | 717.36 | 731.52 | 1,147 | 1,251 | 637.16 |
Cash Growth | 23.25% | -1.93% | -36.23% | -8.31% | 96.35% | 4.10% |
Accounts Receivable | 1,070 | 1,154 | 1,589 | 1,834 | 2,136 | 1,924 |
Other Receivables | 36.9 | 103.09 | 23.3 | 27.65 | 19.41 | 21.61 |
Receivables | 1,107 | 1,257 | 1,613 | 1,861 | 2,155 | 1,946 |
Inventory | 861.32 | 849.13 | 901.58 | 907.49 | 1,039 | 1,076 |
Other Current Assets | 319.57 | 404.09 | 393.84 | 306.33 | 251.87 | 195.77 |
Total Current Assets | 3,181 | 3,228 | 3,640 | 4,222 | 4,698 | 3,855 |
Property, Plant & Equipment | 3,654 | 3,812 | 3,407 | 2,929 | 2,513 | 2,015 |
Long-Term Investments | 140.33 | 145.68 | 173.93 | 172.73 | 193.81 | 144.12 |
Goodwill | 51.04 | 51.04 | 51.04 | 145.15 | 145.15 | 21.32 |
Other Intangible Assets | 391.19 | 402.1 | 375.16 | 283.25 | 269.37 | 194.61 |
Long-Term Deferred Tax Assets | 184.09 | 158.86 | 133.78 | 153.86 | 161.45 | 161.18 |
Long-Term Deferred Charges | 122.27 | 119.2 | 119.6 | 142.4 | 113.42 | 95.51 |
Other Long-Term Assets | 75.92 | 77.59 | 75.71 | 70.19 | 74.45 | 79.77 |
Total Assets | 7,800 | 7,995 | 7,976 | 8,119 | 8,168 | 6,567 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 215.87 | 208.67 | 316.75 | 365.85 | 380.89 | 317.43 |
Accrued Expenses | 72.34 | 102.18 | 136.39 | 136.86 | 152.61 | 131.59 |
Short-Term Debt | 134.65 | 258.96 | 255.1 | 144.65 | 248.08 | 530.56 |
Current Portion of Long-Term Debt | 99.17 | 155.95 | 202.42 | 330.56 | 139.1 | 130 |
Current Portion of Leases | - | 5.19 | 8.86 | 14.48 | 13.2 | 13.64 |
Current Income Taxes Payable | 5.72 | 3.14 | 5.69 | 19.31 | 39.84 | 23.6 |
Current Unearned Revenue | 107.6 | 100.18 | 72.04 | 72.36 | 74.41 | 77 |
Other Current Liabilities | 134.86 | 219.1 | 198.71 | 36.54 | 35.22 | 89.35 |
Total Current Liabilities | 770.21 | 1,053 | 1,196 | 1,121 | 1,083 | 1,313 |
Long-Term Debt | 594.49 | 521.87 | 184.12 | 162.5 | 285.8 | 424.1 |
Long-Term Leases | 5.18 | 4.3 | 6.79 | 12.98 | 15.04 | 17.15 |
Long-Term Unearned Revenue | 24.33 | 24.69 | 23.83 | 28.8 | 31.07 | 28.1 |
Long-Term Deferred Tax Liabilities | 71.17 | 77.92 | 134 | 179.07 | 223.72 | 242.65 |
Other Long-Term Liabilities | 1.5 | 6.75 | 7.94 | 3.83 | - | - |
Total Liabilities | 1,467 | 1,689 | 1,553 | 1,508 | 1,639 | 2,025 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 604.67 | 604.67 | 612.47 | 612.47 | 612.47 | 556.47 |
Additional Paid-In Capital | 1,592 | 1,592 | 1,783 | 1,781 | 1,781 | 279.51 |
Retained Earnings | 4,120 | 4,080 | 4,179 | 4,147 | 4,047 | 3,624 |
Treasury Stock | -10.81 | - | -220.24 | -170.18 | -170.18 | -170.18 |
Comprehensive Income & Other | -2.98 | -1.07 | 14.18 | 14.89 | 23.29 | 8.34 |
Total Common Equity | 6,303 | 6,276 | 6,369 | 6,385 | 6,293 | 4,299 |
Minority Interest | 30.07 | 30.03 | 54.61 | 226.64 | 236.25 | 243.16 |
Shareholders' Equity | 6,333 | 6,306 | 6,424 | 6,611 | 6,529 | 4,542 |
Total Liabilities & Equity | 7,800 | 7,995 | 7,976 | 8,119 | 8,168 | 6,567 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 833.5 | 946.27 | 657.29 | 665.17 | 701.22 | 1,115 |
Net Cash (Debt) | 60.05 | -228.9 | 74.23 | 481.94 | 549.84 | -478.29 |
Net Cash Growth | - | - | -84.60% | -12.35% | - | - |
Net Cash Per Share | 0.10 | -0.38 | 0.12 | 0.79 | 0.90 | -0.86 |
Filing Date Shares Outstanding | 604.01 | 604.67 | 608.51 | 606.83 | 612.47 | 556.47 |
Total Common Shares Outstanding | 604.01 | 604.67 | 608.51 | 606.83 | 612.47 | 556.47 |
Working Capital | 2,411 | 2,175 | 2,444 | 3,102 | 3,614 | 2,542 |
Book Value Per Share | 10.44 | 10.38 | 10.47 | 10.52 | 10.27 | 7.72 |
Tangible Book Value | 5,861 | 5,823 | 5,943 | 5,956 | 5,879 | 4,083 |
Tangible Book Value Per Share | 9.70 | 9.63 | 9.77 | 9.82 | 9.60 | 7.34 |
Buildings | - | 1,907 | 783.53 | 783.35 | 739.86 | 732.5 |
Machinery | - | 2,868 | 2,508 | 2,304 | 1,993 | 1,808 |
Construction In Progress | - | 221 | 1,103 | 714.48 | 504.01 | 76.97 |